13th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 1998

January 24-31, 1998
Marilleva, Trento, Italy

RT-33

Sensitivity and specificity of head-up tilt testing with orciprenaline

Sven Reek, Daniela Polywka, Helmut U. Klein.
Department of Cardiology, University Hospital Magdeburg, Magdeburg, Germany

Abstract

Purpose. The ideal protocol for head-up tilt testing is still a matter of debate. Head-up tilt testing with low-dose isoprenaline has an acceptable high sensitivity and specificity. The purpose of our study was to evaluate the sensitivity and specificity of head-up tilt testing using orciprenaline.
Methods. Head-up tilt testing was performed in 24 patients (11 male, 13 female, mean age 35.9 years) with > 1 syncope and in 30 healthy volunteers (18 male, 12 female, mean age 26 years) without any history of syncope. Subjects were tilted 70 degrees for 45 min at baseline. Then orciprenaline infusion was titrated to achieve a 30% increase in heart rate. A second head-up tilt testing was performed for 15 minutes thereafter with a pause of 15 minutes in between both tests. Electrocardiogram was recorded and blood pressure was continuously measured noninvasively. A positive head-up tilt test was defined as a decrease of blood pressure of > 30 mmHg or a drop in heart rate of > 30 bpm combined with syncope or presyncope.
Results. Eight (33%) of 24 patients with a history of syncope had positive baseline head-up tilt testings, another 9 patients (38%) had positive head-up tilt testings with orciprenaline and in 7 patients (29%) we found a negative result at baseline testing as well as with orciprenaline. The sensitivity of the complete protocol for patients with > 1 syncope was 71%. There was only one of 30 volunteers (3%) who had a positive result at baseline testing. Two additional volunteers had positive head-up tilt testings with orciprenaline. The specificity of our baseline head-up tilt testing was 97 and 90% with orciprenaline respectively.
Conclusion. Adding orciprenaline as an additional part of head-up tilt testing has an acceptable high sensitivity and a good specificity in the evaluation of patients with neurocardiogenic syncope. Our results are comparable to protocols using low-dose isoprenaline.

Key Words

Syncope
head-up tilt testing, orciprenaline, OA

 

forward

CARDIOnet® - registered trade mark name
Copyright © 1996-1998 by CARDIOnet. All rights reserved.